Wall Street stocks closed lower on Friday as market participants reacted to news that Israel launched an airstrike on Iran.

The phase 1b trial’s primary endpoints are the occurrence of adverse events, including dose-limiting toxicities, and the ...

Senators Bernie Sanders and Angus King plan to introduce a bill to ban pharmaceutical companies from direct-to-consumer ...

Johnson & Johnson said the first clinical data from its ongoing Phase 1b study of JNJ-4496, a chimeric antigen receptor T-cell therapy, shows encouraging potential in treating large B-cell lymphoma, ...

Johnson & Johnson announced new Phase 1b data showing antileukemic activity and a safety profile for bleximenib in ...

The index fell from Thursday's close just under 43,000 to open near 42,500. Visa (V) shed 4.6%, Sherwin-Williams (SHW) lost 3 ...

Major indices were in the red early on Friday as market participants reacted to news that Israel launched an airstrike on ...

Olstein Capital Management sold 6.2% of its Johnson & Johnson shares in Q1, trimming 4,000 shares from its portfolio. Johnson ...

Johnson & Johnson is a diversified healthcare giant. J&J has increased its dividend for 63 consecutive years. One high-yield ...

Investing.com -- Kenvue Inc (NYSE: KVUE) stock dropped 1.6% aftermarket on Thursday following reports that the consumer health company is considering divesting several smaller brands from its skin ...

Kenvue is exploring the sale of some of its skin health and beauty brands, four people familiar with the matter said on ...